Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammation

Autor: Nikunj Sharma, David R Sweet, Panjamaporn Sangwung, Yoichi Takami, Neelakantan T Vasudevan, Anthony Wynshaw-Boris, Paul Holvoet, Yuan Lu, Liyan Fan, Xudong Liao, Stanton L. Gerson, E. Ricky Chan, Chen Fu, Chloe E Booth, Vinesh Vinayachandran, Guangjin Zhou, Lilei Zhang, Keiichiro Matoba, Yulan Qing, Komal S Keerthy, Mukesh K. Jain, Lalitha Nayak, Derin Tugal
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Central Nervous System
Male
Myeloid
Regulator
General Physics and Astronomy
Eating
Mice
0302 clinical medicine
Myeloid Cells
lcsh:Science
Mice
Knockout

INSULIN-RESISTANCE
Multidisciplinary
KLF2
Type 2 diabetes
Metabolic syndrome
Multidisciplinary Sciences
medicine.anatomical_structure
OBESITY
Knockout mouse
Science & Technology - Other Topics
medicine.symptom
EXPRESSION
Science
Kruppel-Like Transcription Factors
Inflammation
Diet
High-Fat

General Biochemistry
Genetics and Molecular Biology

Article
03 medical and health sciences
Insulin resistance
Immune system
Metabolic Diseases
Peripheral Nervous System
medicine
Animals
Humans
Obesity
Science & Technology
business.industry
General Chemistry
medicine.disease
030104 developmental biology
Cancer research
lcsh:Q
JNK
Insulin Resistance
business
030217 neurology & neurosurgery
Microglial cells
Zdroj: Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
ISSN: 2041-1723
Popis: Substantial evidence implicates crosstalk between metabolic tissues and the immune system in the inception and progression of obesity. However, molecular regulators that orchestrate metaflammation both centrally and peripherally remains incompletely understood. Here, we identify myeloid Krüppel-like factor 2 (KLF2) as an essential regulator of obesity and its sequelae. In mice and humans, consumption of a fatty diet downregulates myeloid KLF2 levels. Under basal conditions, myeloid-specific KLF2 knockout mice (K2KO) exhibit increased feeding and weight gain. High-fat diet (HFD) feeding further exacerbates the K2KO metabolic disease phenotype. Mechanistically, loss of myeloid KLF2 increases metaflammation in peripheral and central tissues. A combination of pair-feeding, bone marrow-transplant, and microglial ablation implicate central and peripheral contributions to K2KO-induced metabolic dysfunction observed. Finally, overexpression of myeloid KLF2 protects mice from HFD-induced obesity and insulin resistance. Together, these data establish myeloid KLF2 as a nodal regulator of central and peripheral metabolic inflammation in homeostasis and disease.
Inflammation contributes to the development of metabolic disease through incompletely understood mechanisms. Here the authors report that deletion of the transcription factor KLF2 in myeloid cells leads to increased feeding and weight gain in mice with concomitant peripheral and central tissue inflammation, while overexpression protects against diet-induced metabolic disease.
Databáze: OpenAIRE